We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Didn't Infringe Invalid Mirapex Patent: Judge

Law360 (May 13, 2009, 12:00 AM EDT) -- Boehringer Ingelheim Pharmaceuticals Inc. on Wednesday lost its bid to hold Mylan Pharmaceuticals Inc. accountable for allegedly infringing its patent covering restless leg syndrome treatment Mirapex after a federal judge agreed...
To view the full article, register now.